Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)
- 1 July 2009
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 45 (11) , 986-990
- https://doi.org/10.1016/j.oraloncology.2009.05.635
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland CarcinomaTranslational Oncology, 2008
- High-resolution array comparative genomic hybridization analysis of human bronchial and salivary adenoid cystic carcinomaLaboratory Investigation, 2008
- A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glandsOral Oncology, 2007
- Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium StudyJournal of Clinical Oncology, 2005
- A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patientGastroenterology, 2004
- HER-2/neu Assessment in Primary Chemotherapy Treated Breast Carcinoma: No Evidence of Gene Profile ChangingBreast Cancer Research and Treatment, 2003
- Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinomaCancer Letters, 2000
- The world health organization's histological classification of salivary gland tumors. A commentary on the second editionCancer, 1992
- Histogenesis of salivary gland neoplasms: a postulate with prognostic implicationsThe Journal of Laryngology & Otology, 1989
- Histology of the Major Salivary GlandsThe American Journal of Surgical Pathology, 1989